Anthony Ferrari
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Breast Cancer Specificities of Patients With Anti-Ri Paraneoplastic Neurologic Syndromes.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 17, 2025
Intricate ribosome composition and translational reprogramming in epithelial-mesenchymal transition.
Intricate ribosome composition and translational reprogramming in epithelial-mesenchymal transition.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 05, 2024
Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location.
Journal: Journal of neuro-oncology
Published: May 02, 2024
Interleukin-35 impairs human NK cell effector functions and induces their ILC1-like conversion with tissue residency features.
Journal: Nature communications
Published: March 07, 2024
The NF-κB RelA transcription factor is not required for CD8+ T-cell function in acute viral infection and cancer.
Journal: Frontiers in immunology
Published: January 31, 2024
Comprehensive molecular portrait reveals genetic diversity and distinct molecular subtypes of small intestinal neuroendocrine tumors.
Journal: Nature communications
Published: January 20, 2024
Added value of whole-exome and RNA sequencing in advanced and refractory cancer patients with no molecular-based treatment recommendation based on a 90-gene panel.
Journal: Cancer medicine
Published: September 25, 2023
Isocitrate dehydrogenase wt and IDHmut adult-type diffuse gliomas display distinct alterations in ribosome biogenesis and 2'O-methylation of ribosomal RNA.
Journal: Neuro-oncology
Published: August 02, 2023
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma.
Journal: Nature communications
Published: February 25, 2023
Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas.
Journal: Cancer research communications
Published: December 28, 2022
Last Updated: 09/26/2026